Implantica (Sweden) Today
| IMP-A-SDB | SEK 37.35 0.30 0.80% |
Performance0 of 100
| Odds Of DistressOver 68
|
Implantica is selling for under 37.35 as of the 27th of November 2024; that is 0.8 percent decrease since the beginning of the trading day. The stock's lowest day price was 37.0. Implantica has more than 68 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Implantica AG are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
Implantica AG, a medtech company, researches, develops, and sells medical implants for unmet medical needs in Switzerland. The company was founded in 2015 and is based in Vaduz, Liechtenstein. Implantica is traded on Stockholm Stock Exchange in Sweden. More on Implantica AG
Moving together with Implantica Stock
| 0.74 | XVIVO | Xvivo Perfusion AB | PairCorr |
| 0.63 | BICO | BICO Group AB | PairCorr |
| 0.8 | BACTI-B | Bactiguard Holding | PairCorr |
| 0.75 | ADDV-B | ADDvise Group B | PairCorr |
Moving against Implantica Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Implantica Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Implantica's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Implantica or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Implantica AG (IMP-A-SDB) is traded on Stockholm Exchange in Sweden and employs 29 people. The company operates under Healthcare sector and is part of Medical Devices industry.
Implantica AG has accumulated about 147.29 M in cash with (11.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.12.
Check Implantica Probability Of Bankruptcy
Ownership AllocationRoughly 71.42 (percent) of Implantica outstanding shares are held by general public with 28.58 pct. by outside corporations.
Check Implantica Ownership Details
Implantica AG Risk Profiles
Although Implantica's alpha and beta are two of the key measurements used to evaluate Implantica's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.81 | |||
| Standard Deviation | 2.5 | |||
| Variance | 6.26 | |||
| Risk Adjusted Performance | (0.09) |
Implantica Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Implantica without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
| All Next | Launch Module |
Implantica Corporate Management
Elected by the shareholders, the Implantica's board of directors comprises two types of representatives: Implantica inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Implantica. The board's role is to monitor Implantica's management team and ensure that shareholders' interests are well served. Implantica's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Implantica's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stephan Siegenthaler | Chief Member | Profile | |
| Nicole Pehrsson | Chief Officer | Profile | |
| Andreas hrnberg | Chief Officer | Profile | |
| Paul Mead | Chief Officer | Profile | |
| Stefan Vogt | Chief Officer | Profile | |
| Steffen Schanz | VP Management | Profile | |
| Amit Kukreja | Chief Officer | Profile |
Additional Tools for Implantica Stock Analysis
When running Implantica's price analysis, check to measure Implantica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Implantica is operating at the current time. Most of Implantica's value examination focuses on studying past and present price action to predict the probability of Implantica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Implantica's price. Additionally, you may evaluate how the addition of Implantica to your portfolios can decrease your overall portfolio volatility.